You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 154 No. 4, 28 February 1994 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (3)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Aspirin, NSAIDs, and Risk Reduction of Colorectal Cancer

The Problem Is Translation

David M. Waterhouse, MD, MPH; Dean Brenner, MD

Arch Intern Med. 1994;154(4):366-368.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

CANCERS OF the colon and rectum cumulatively account for approximately 15% of all visceral tumors, affecting about one person in 20 in the United States and most other Western countries. Rapid advances in molecular biology may soon allow for genetic screening of individuals at risk for the development of colorectal cancer. The gene for familial adenomatous polyposis has been cloned and sequenced, and recently the gene coding for hereditary nonpolyposis colorectal cancer has been mapped to a locus on chromosome 2.1 Familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer may account for as much as 5% to 14% of all colorectal cancer in industrialized nations, but men and women over the age of 40 years still constitute the the largest population at risk.

During the last several decades, the incidence of these cancers has remained relatively constant, although there has been a progressive trend toward disease of the more . . . [Full Text PDF of this Article]


Author Affiliations

Oncology Consultants 199 W.H. Taft Rd, Ste 101 Cincinnati, OH 45219; Departments of Internal Medicine and Pharmacology University of Michigan Medical School Medical Service Veterans Affairs Medical Center Ann Arbor, MI 48109



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.